STEMCELL2MAX

A novel solution to efficient Haematopoietic Stem Cell regeneration

 Coordinatore INSTITUTO DE MEDICINA MOLECULAR 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Portugal [PT]
 Totale costo 163˙600 €
 EC contributo 149˙885 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2013-PoC
 Funding Scheme CSA-SA(POC)
 Anno di inizio 2014
 Periodo (anno-mese-giorno) 2014-03-01   -   2015-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    INSTITUTO DE MEDICINA MOLECULAR

 Organization address address: AVENIDA PROF EGAS MONIZ
city: LISBOA
postcode: 1649 028

contact info
Titolo: Dr.
Nome: Joana
Cognome: Costa
Email: send email
Telefono: +351 217999411

PT (LISBOA) hostInstitution 149˙885.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

stem    cells    hscs    cell    commercial    culture    hsc    expansion   

 Obiettivo del progetto (Objective)

'There is an urgent need for improved expansion protocols for haematopoietic stem cells (HSCs). Many studies have tried to stimulate HSC expansion by experimenting with cytokine cocktails in cell culture media. Although these combinations of growth factors are able to increase the amount of HSCs, this happens at the cost of cell maturation: many of the cells in the final culture have lost their 'stemness' and thus their use for treatment and R&D. Dr. Veiga Fernandes has identified crucial survival factors for HSC expansion that increase the stem cell yield 20-fold compared to the current state-of-the-art. This dramatic increase poses serious commercial and societal opportunities. In this ERC PoC project a team of technological and commercial experts will investigate the commercial feasibility of this potentially groundbreaking approach and aims to design the optimal route-to-market with the ultimate goal to attract investors and other strategic partners.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

2-HIT (2008)

Genetic interaction networks: From C. elegans to human disease

Read More  

HLA-DR15 IN MS (2015)

Functional Role of the HLA-DR15 Haplotype in Multiple Sclerosis

Read More  

FUNCMOLQIP (2011)

Design and Preparation of Functional Molecules for Quantum Computing and Information Processing

Read More